Chronic Lymphocytic Leukemia — Trials

Chronic Lymphocytic Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

1,256 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 265
Recruiting: 123
Ph III recruiting: 16
Growth YoY: −16.3%
Industry share: 33%
Top sponsor: City of Hope Medical Center
Termination share: 34.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (239)

clinicaltrialsPublishedShowing 651–700 of 1,256 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02265731	Study Evaluating Venetoclax in Subjects With Hematological Malignancies	completed	Phase 1 / Phase 2	38	AbbVieINDUSTRY	1	Aug 2, 2021	clinicaltrials
NCT04980859	Zebutinib Combined With Immunochemotherapy in the Treat of Newly Treated CLL Patients Without 17p-/TP53 Mutation	unknown	Phase 3	45	Nanfang Hospital, Southern Medical UniversityOTHER	0	Jul 28, 2021	clinicaltrials